Biopharma News : Biopharma and Pharma news from all around the world :
- Repositive Launches World-Leading Directory of Preclinical Cancer Models on Science Exchange
- GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury
- Bicycle Therapeutics Expands Neuroscience Collaborations to Include Oxford University’s Oxford Drug Discovery Institute
- PredictImmune Announces New Strategic Partnership to Commercialise its PredictSURE IBD™ Prognostic Test for Inflammatory Bowel Disease Across North America
- Citi Appointed as Depositary Bank for Innate Pharma’s ADR Programme
- Syngenta Commits $2 Billion and Sets New Targets for Innovation to Tackle Climate Change
- Takeda Acquires License for First-In-Class Celiac Disease Therapy from COUR Pharmaceuticals Following Positive Phase 2a Proof-of-Concept Study
- Cystic Fibrosis Foundation Statement on FDA Approval of TRIKAFTA, the First Triple-Combination Therapy for the Most Common CF Mutation
- Aradigm Receives Feedback Following an Oral Explanation With the European Medicines Agency
- Growth of Age-Related Macular Degeneration (AMD) Therapeutics Market to be Impacted by the Development of Gene Therapy for AMD | Technavio
- Apollo Health and Beauty Care Granted Research and Development License Under the Cannabis Act
- UnitedHealthcare and Optum Take Action to Support People Affected by Severe Weather, Tornadoes in Dallas Area
- Exicure to Present at 2019 BIO Investor Forum
- Charles River Laboratories Schedules Third-Quarter 2019 Earnings Release and Conference Call
- Veracyte Announces Clinical Data Demonstrating Clinical Validity and Utility of Percepta Classifier in Lung Cancer Diagnosis When Bronchoscopy Results Are Inconclusive
- Vertex to Announce Third-Quarter 2019 Financial Results on October 30
- Enanta Pharmaceuticals to Present at the 2019 Wolfe Research Healthcare Conference
- FDA Approves TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Treat the Underlying Cause of Cystic Fibrosis in People Ages 12 and Older Who Have at Least One F508del Mutation
- Venarum Medical Receives Ongoing NIH SBIR Grant Support for its EndoVenous Valve System Development
- United States Biosimilar Monoclonal Antibodies Market Report 2019: Prospects, Trends Analysis, Market Size and Forecasts up to 2024 – ResearchAndMarkets.com
- Bulk Drug Raw Materials Procurement | Global Market Report 2019 – ResearchAndMarkets.com
- Teva Settles Track 1 Opioid Cases and Reaches Agreement on Framework to Settle Remaining Litigation
- United States Pulmonary Drug Delivery Devices Market Prospects, Trends Analysis, Market Size and Forecasts 2019-2024 – ResearchAndMarkets.com
- Spanish Government Approves National Reimbursement of ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor) in Combination With KALYDECO® (ivacaftor)
- Q2 2019 Pharmaceuticals Partnerships, Licensing, Investments and M&A Deals and Trends – ResearchAndMarkets.com
- United States NRT Smoking Cessation Aids Market Report 2019: Nicorette From GSK Consumer Healthcare Maintaining Dominance – ResearchAndMarkets.com
- United States Cough, Cold and Allergy (Hay Fever) Remedies Markets, 2014-2018 & 2019-2023: Natural Alternatives Lead To Losses Among Some Big Names in Cough and Cold – ResearchAndMarkets.com
- BIOQUAL Presents Unaudited Financial Results for First Quarter of Fiscal Year 2020
- Analgesics Markets in the US, 2019 – Advil Maintains Its Lead in Systemic Analgesics Despite Sales Decline – ResearchAndMarkets.com
- Tiaki Therapeutics Presents Data on Identification of a Novel Target for Neuroinflammatory-driven Neurodegenerative Disease Validated by Its Systems Biology Platform
Biotech – Biopharma News: PR Newswire
.
.
Biotech – Biopharma News!
- Invitation to MorphoSys Q3 2019 Conference Call on October 30, 2019
- CO.DON AG: co.don Aktiengesellschaft decides to increase share capital through rights issue with subscription rights of existing shareholders
- APEIRON to present preclinical data at the 2019 AACR-NCI-EORTC Conference
- 4SC AG: Poster presentation at 1st International Symposium on Merkel Cell Carcinoma
- Great Bay Bio and Boji Medical have Reached Strategic Cooperation to Jointly Develop a Long-Acting Biological and Innovative Anti-Anemia Injection
- ADC Therapeutics Doses First Patients in Pivotal Phase 2 Clinical Trial of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma
- Epigenomics AG decides to increase share capital through rights issue with subscription rights of existing shareholders
- 4SC provides Q3 business update and outlook
- AEVIS VICTORIA SA: Integration of Seiler Hotels in Zermatt
- MetrioPharm AG: MetrioPharm AG Phase II Data in Psoriasis Show Dose-Response, Disease Modifying Activity and Outstanding Safety Profile
- 4SC and Netherlands Cancer Institute Collaborate on Clinical Evaluation of Domatinostat in the Neoadjuvant Setting in Melanoma
- Drägerwerk AG & Co. KGaA: preliminary result for the third quarter. Increased guidance for net sales development.
- Xlife Sciences AG: New project in the portfolio
- Change in the Supervisory Board of MEDICLIN
- MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China (news with additional features)
- JUST – EVOTEC BIOLOGICS & BIOCON BIOLOGICS SIGN LICENSING DEAL FOR A BIOSIMILAR ASSET
- Biofrontera AG: Biofrontera reports preliminary unaudited sales revenue for the first nine months of 2019
- Apogenix to Present at Several Upcoming International Conferences
- Gerresheimer AG: Gerresheimer advances growth and technology projects in third quarter
- 4SC AG: Conference call to be hosted on 17 October 2019 to present the Q3 Announcement 2019
- Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2019
- EVOTEC AND CELMATIX ENTER INTO STRATEGIC COLLABORATION
- MOLOGEN AG: Cooperation with amfAR Institute for HIV Cure Research on clinical combination trial
- Vivoryon Therapeutics AG: NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE WOULD BE UNLAWFUL.
- 4SC AG resolves to issue new shares; Santo and ATS undertake to subscribe / buy the new shares
- Biom’up announces the approval of HEMOBLAST(TM) Bellows and its laparoscopic applicator in Australia
- Expedeon AG: Expedeon AG announces conversion to registered shares (news with additional features)
- EVOTEC REACHES MILESTONE IN INTEGRATED DRUG DISCOVERY AND DEVELOPMENT PARTNERSHIP WITH AEOVIAN
- Heidelberg Pharma AG Announces Adjustment of Guidance
- Epigenomics AG: Results from Microsimulation Model to be presented at renowned health conference
- Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 22 November 2019 have been made available
- Kiadis Pharma announces formation of renowned Scientific Advisory Board
- Idorsia announces financial results for the first nine months of 2019
- Novartis delivered another strong quarter with double digit sales growth and core1 margin expansion; 2019 sales and profit guidance raised; Beovu launched in US
- NewLink Genetics Announces EU Regulatory Committee (CHMP) Recommendation for Conditional Marketing Authorization for Ebola Vaccine V920 (ERVEBO®)
- GENFIT: Combined Shareholders’ Meeting of November 27, 2019 – Availability of Preparatory Documents
- Innate Pharma Announces Closing of Global Offering
- Ascendis Pharma A/S Receives Orphan Designation for TransCon™ hGH for the Treatment of Pediatric Growth Hormone Deficiency in Europe
- Align Technology’s Invisalign Brand Becomes the Official Smile of the New England Patriots and New England Revolution
- Exactus, Inc. Will Appear on The National Business Show Today at 3PM EDT
- Cytovance® Biologics Introduces an Integrated Single-use Platform for Plasmid DNA (pDNA) Manufacture
- Assertio Therapeutics Provides Regulatory Update on Long-Acting Cosyntropin
- NTI™ (Northgate Technologies, Inc.) Receives Innovative Technology Contract from Vizient for NEBULAE™ I System, High-flow Laparoscopic Insufflator
- Seelos Therapeutics Announces Amendment of SLS-002 Agreement
- Immunicum AB (publ) Announces Positive Preclinical Data on Ilixadencel in Combination with CTLA-4 Immune Checkpoint Inhibitor
- Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline
- Nexstim Plc: Amendments to the Notice of the Extraordinary General Meeting of Shareholders
- Nexstim has secured 100 per cent of the Warrant Plan 2019 and decided on a directed issue of approximately EUR 1.1 million subject to the approval of the Extraordinary General Meeting
- The share subscription period for Nexstim Plc’s Warrant Plan 2019 starts on 22 October 2019
- Vamorolone Designated Promising Innovative Medicine (PIM) for Treatment of Duchenne Muscular Dystrophy by the UK MHRA
- Roche’s Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma
- TLC Appoints Vincent Chang, PhD, as Vice President of Manufacturing Development
- NGM Bio to Present at Upcoming Investor Conferences
- Cytovance Biologics to Participate in RAFT Scientific Discussion on Commercialization of Fermentation Processes
- Pure Global Cannabis Announces Board Change
- UPDATE — Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
- Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers
- CytomX Therapeutics Announces New Employment Inducement Grants
- Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Cream USP, 0.1% (Gentamicin Base)
- Pauric Duffy and Peter Comerford Announce Conversion of Preferred Shares of The Flowr Corporation
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !